TCL Archive White House Okays Committee ‘Kill’ Lists; Workshops To Plan Projects In Carcinogenesis July 22, 1977
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive Penn Begins Clinical Trial Of A Vaccine For Breast Cancer Based On Telomerase February 27, 2004